Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16150584 | 0.93 | MLYCD (0.40) | MLYCDPDK2ADORA2AADORA2BADORA1 | |
| SCHEMBL17829477 | 0.89 | MLYCD (0.37) | MLYCD | |
| SCHEMBL17829476 | 0.85 | MLYCD (0.40) | MLYCDPDK2ADORA2AADORA2BADORA1 | |
| SCHEMBL16150672 | 0.82 | MLYCD (0.37) | MLYCD | |
| SCHEMBL17178349 | 0.79 | MLYCD (0.41) | MLYCDPDK2HSD11B1 | |
| SCHEMBL29379234 | 0.78 | MLYCD (0.40) | MLYCDADORA2AADORA2BADORA1 | |
| SCHEMBL15671140 | 0.78 | MLYCD (0.40) | MLYCDADORA2AADORA2BADORA1 | |
| SCHEMBL16863608 | 0.77 | MLYCD (0.39) | MLYCDADORA2AADORA2BADORA1 | |
| SCHEMBL17178329 | 0.75 | MLYCD (0.43) | MLYCDADORA2AADORA2BADORA1HSD11B1 | |
| SCHEMBL17178350 | 0.75 | MLYCD (0.43) | MLYCDPDK2ADORA2AADORA2BADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9598369-B2 | Process for the preparation of amides from hindered anilines containing a perhaloalkyl group | SYNGENTA PARTICIPATIONS AG (CH) | 2017-03-21 | — | — | US | disclosed |
| US-20160168097-A1 | PROCESS FOR THE PREPARATION OF AMIDES FROM HINDERED ANILINES CONTAINING A PERHALOALKYL GROUP | SYNGENTA PARTICIPATIONS AG (CH) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168097-A1 | PROCESS FOR THE PREPARATION OF AMIDES FROM HINDERED ANILINES CONTAINING A PERHALOALKYL GROUP | ABHD5, FADS1, PFAS | MLYCD 1591/4885PDK2 587/4885ADORA2A 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.